Search

everythinglearnresearchcommunity

for

Search:↓

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Injectable platelet-rich fibrin is a safe and effective treatment for hair loss.

The finasteride nanogel could be an effective topical treatment for hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Nerve growth factor helps improve healing time and scar quality in burn wounds.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Eyebrow hair transplants in patients with frontal fibrosing alopecia may look good at first but often lose the new hair after a few years.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

The N-K GM Series offers a new method to reduce aflatoxin poisoning and cancer, improving health and saving costs in affected regions.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Dr. Jia-You Fang is a highly experienced researcher in drug delivery and related fields, with numerous publications and international collaborations.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

A special dressing called FEA-PCEI can speed up wound healing, reduce scars, and help grow new hair follicles, but only at the right dosage.

Adalimumab improved folliculitis decalvans in most patients.

Trichoscopy helps diagnose frontal fibrosing alopecia in Caucasians, but more research is needed.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.